Ost-müük Eyenovia, Inc. - EYEN CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | - | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024874% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.002651% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | N/A |
Avatud* | N/A |
Aastane muutus* | N/A |
Päeva ulatus* | N/A |
52 nädala ulatus | 1.50-3.68 |
Keskmine maht (10 päeva) | 187.37K |
Keskmine maht (3 kuud) | 4.28M |
Turukapitalisatsioon | 127.51M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 36.12M |
Tulu | 10.00M |
EPS | -0.56 |
Dividendid (% kasumist) | N/A |
Beeta | 1.70 |
Järgmine tuluaruande kuupäev | May 10, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|
Eyenovia, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kogutulu | 14 | 2 | 0 | 0 | 0 |
Tulu | 14 | 2 | 0 | ||
Kogu tegevuskulu | 26.4403 | 21.7892 | 21.3085 | 17.2564 | 5.13237 |
Müük/Üldine/admin kulud, kokku | 10.7842 | 7.69759 | 7.20051 | 6.13618 | 1.31564 |
Uuringud ja arendus | 14.2979 | 13.1962 | 14.0927 | 11.1011 | 3.79127 |
Depreciation / Amortization | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
Tulud majandustegevusest | -12.4403 | -19.7892 | -21.3085 | -17.2564 | -5.13237 |
Intressitulud (kulu), muud tulud, neto | -0.38524 | 0.00936 | 0.15179 | 0.00334 | 0.00238 |
Netotulu enne makse | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Netotulu pärast makse | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Netotulu enne erikulusid | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Netotulu | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Arvestatav tulu, v a erikulud | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Arvestatav tulu, koos erikuludega | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Jaotuse korrigeerimine | |||||
Jaotamisele kuuluv netotulu | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Keskmine jaotamisele kuuluv aktsia kohta | 26.3241 | 21.0547 | 14.3497 | 9.47671 | 9.93677 |
Jaotatav EPS, v a erakorralised kulud | -0.48543 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
Dividends per Share - Common Stock Primary Issue | |||||
Jaotamisele kuuluv normaal-EPS | -0.50303 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
Erakorralised kulud kokku | 0 | ||||
Kulud, Kokku | 1.6 | 0.8 | |||
Brutokasum | 12.4 | 1.2 | |||
Muud, neto | 0.04718 | 0.01 | |||
Ootamatud kulutused (tulu) | -0.46335 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 10 | 0 |
Tulu | 0 | 0 | 0 | 10 | 0 |
Kulud, Kokku | 0 | 0 | 0 | 0 | 0 |
Brutokasum | 0 | 0 | 0 | 10 | 0 |
Kogu tegevuskulu | 7.23023 | 7.12146 | 7.18755 | 6.88673 | 5.46171 |
Müük/Üldine/admin kulud, kokku | 3.35335 | 3.53459 | 3.47497 | 3.7115 | 2.373 |
Uuringud ja arendus | 3.87688 | 3.58687 | 3.71258 | 3.17523 | 3.55207 |
Tulud majandustegevusest | -7.23023 | -7.12146 | -7.18755 | 3.11327 | -5.46171 |
Intressitulud (kulu), muud tulud, neto | -0.14905 | -0.15102 | -0.14505 | -0.18519 | -0.11861 |
Muud, neto | 0.07028 | 0.03338 | -0.00707 | 0.05519 | 0.01173 |
Netotulu enne makse | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Netotulu pärast makse | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Netotulu enne erikulusid | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Netotulu | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Arvestatav tulu, v a erikulud | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Arvestatav tulu, koos erikuludega | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Jaotamisele kuuluv netotulu | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Keskmine jaotamisele kuuluv aktsia kohta | 34.6318 | 33.6449 | 30.0082 | 27.977 | 26.0535 |
Jaotatav EPS, v a erakorralised kulud | -0.21105 | -0.21516 | -0.24459 | 0.10663 | -0.21374 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.21105 | -0.21516 | -0.24459 | 0.10663 | -0.23152 |
Ootamatud kulutused (tulu) | 0 | 0 | -0.46335 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 29.8769 | 33.3913 | 14.3493 | 19.861 | 5.28666 |
Raha ja lühiajalised investeeringud | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
Cash | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
Prepaid Expenses | 0.38663 | 0.2898 | 0.07737 | 0.13276 | 0.03715 |
Total Assets | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
Property/Plant/Equipment, Total - Net | 1.27123 | 0.39638 | 0.23054 | 0.03674 | 0.02796 |
Property/Plant/Equipment, Total - Gross | 1.59963 | 0.57329 | 0.31203 | 0.10289 | 0.07498 |
Accumulated Depreciation, Total | -0.32841 | -0.17691 | -0.08149 | -0.06615 | -0.04702 |
Total Current Liabilities | 11.1725 | 18.1984 | 2.91166 | 3.09884 | 0.55265 |
Accounts Payable | 1.6141 | 1.46167 | 1.54136 | 1.50952 | 0.24638 |
Accrued Expenses | 2.32693 | 2.57974 | 1.31332 | 1.56769 | 0.29529 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.08109 | 14.0594 | 0.05698 | 0.02163 | 0.01098 |
Total Liabilities | 11.1924 | 18.6029 | 2.95701 | 3.14043 | 0.55265 |
Total Long Term Debt | 0 | 0.36581 | 0 | 0 | 0 |
Other Liabilities, Total | 0.01995 | 0.03868 | 0.04535 | 0.04158 | 0 |
Total Equity | 20.4666 | 15.3039 | 11.7406 | 16.8751 | 5.09067 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Preferred Stock - Non Redeemable, Net | 0.00046 | ||||
Common Stock | 0.00284 | 0.0025 | 0.00171 | 0.00115 | 0.00026 |
Additional Paid-In Capital | 110.683 | 92.7423 | 69.41 | 53.3882 | 24.3511 |
Retained Earnings (Accumulated Deficit) | -90.2193 | -77.4409 | -57.6711 | -36.5143 | -19.2612 |
Total Liabilities & Shareholders’ Equity | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
Total Common Shares Outstanding | 28.4266 | 24.9786 | 17.1007 | 11.469 | 9.93677 |
Other Long Term Assets, Total | 0.51098 | 0.11904 | 0.1178 | 0.1178 | 0.3287 |
Laekumata arved, neto | 2.14885 | 3.11798 | 0.09523 | ||
Other Current Assets, Total | 7.87953 | 1.61173 | 0.02408 | ||
Current Port. of LT Debt/Capital Leases | 7.15037 | 0.09754 | |||
Long Term Debt | 0 | 0.36581 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 30.3986 | 29.8769 | 23.4593 | 29.495 | 28.0252 |
Raha ja lühiajalised investeeringud | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
Cash | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
Laekumata arved, neto | 1.85222 | 2.14885 | 1.25767 | 1.17134 | 1.17891 |
Prepaid Expenses | 1.79656 | 0.38663 | 0.77768 | 1.04895 | 1.089 |
Other Current Assets, Total | 0.03358 | 7.87953 | 7.92312 | 0.09787 | 0.85025 |
Total Assets | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
Property/Plant/Equipment, Total - Net | 1.37036 | 1.27123 | 1.4132 | 0.96888 | 0.70742 |
Other Long Term Assets, Total | 8.41907 | 0.51098 | 0.11904 | 0.11904 | 0.11904 |
Total Current Liabilities | 10.3788 | 11.1725 | 20.7194 | 14.5598 | 16.3656 |
Accounts Payable | 1.53476 | 1.6141 | 1.68473 | 1.66763 | 1.81512 |
Accrued Expenses | 1.05726 | 2.32693 | 1.68645 | 1.86687 | 1.7253 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.74012 | 7.15037 | 7.28204 | 0.95976 | 0.78382 |
Other Current Liabilities, Total | 0.04662 | 0.08109 | 10.0662 | 10.0656 | 12.0414 |
Total Liabilities | 10.3939 | 11.1924 | 20.7454 | 21.5924 | 16.7115 |
Total Long Term Debt | 0 | 0 | 0 | 6.99489 | 0.30729 |
Long Term Debt | 0 | 0 | 6.99489 | 0.30729 | |
Other Liabilities, Total | 0.01508 | 0.01995 | 0.02606 | 0.03763 | 0.03863 |
Total Equity | 29.7942 | 20.4666 | 4.24614 | 8.99056 | 12.1401 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Common Stock | 0.00317 | 0.00284 | 0.0026 | 0.0026 | 0.00256 |
Additional Paid-In Capital | 127.35 | 110.683 | 97.4461 | 96.6219 | 94.9301 |
Retained Earnings (Accumulated Deficit) | -97.559 | -90.2193 | -93.2026 | -87.634 | -82.7926 |
Total Liabilities & Shareholders’ Equity | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
Total Common Shares Outstanding | 31.6984 | 28.4266 | 25.9632 | 25.9466 | 25.6236 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Raha majandustegevusest | -20.8744 | -6.38428 | -18.9193 | -13.1111 | -4.73111 |
Raha majandustegevusest | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
Mittelikviidsed varad | 2.43593 | 2.48317 | 2.51194 | 1.61547 | 0.41231 |
Cash Taxes Paid | |||||
Makstud intressid | 0.22717 | 0.01397 | |||
Muutused tööjõus | -10.7535 | 10.807 | -0.28984 | 2.50737 | -0.0389 |
Tulu investeeringutelt | -1.61852 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
Kapitalikulutused | -1.22658 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
Muud rahavood investeeringutelt, kokku | -0.39194 | ||||
Rahavood investeeringutelt | 21.458 | 20.8648 | 13.5104 | 27.6177 | 6.60357 |
Aktsiate emiteerimine (tagasiost), neto | 14.7299 | 20.8766 | 13.5104 | 27.6177 | 6.60357 |
Rahaline kogumuutus | -1.03498 | 14.2192 | -5.5756 | 14.4787 | 1.86222 |
Laenu väljastamine (kustutamine), neto | 6.72802 | -0.01186 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -21.8878 | -14.5788 | -7.33967 | -12.7784 | -15.7617 |
Cash From Operating Activities | -19.7006 | -12.8836 | -8.1844 | -20.8744 | -14.9978 |
Cash From Operating Activities | 0.2289 | 0.1459 | 0.07543 | 0.22156 | 0.14825 |
Non-Cash Items | 3.16233 | 1.99834 | 0.9352 | 2.43593 | 1.65033 |
Cash Interest Paid | 0.31555 | 0.19937 | 0.09559 | 0.22717 | 0.13184 |
Changes in Working Capital | -1.20409 | -0.44908 | -1.85537 | -10.7535 | -1.03471 |
Cash From Investing Activities | -0.56296 | -0.39964 | -0.20766 | -1.61852 | -1.16507 |
Capital Expenditures | -0.50937 | -0.28134 | -0.17457 | -1.22658 | -1.16507 |
Cash From Financing Activities | 18.2003 | 15.328 | 15.6465 | 21.458 | 9.16692 |
Financing Cash Flow Items | -0.08339 | -0.08339 | -0.08339 | ||
Issuance (Retirement) of Stock, Net | 18.9591 | 15.8604 | 15.8417 | 14.7299 | 2.28079 |
Issuance (Retirement) of Debt, Net | -0.67533 | -0.449 | -0.11179 | 6.72802 | 6.88612 |
Net Change in Cash | -2.06325 | 2.04473 | 7.25442 | -1.03498 | -6.99596 |
Cash Taxes Paid | 0 | ||||
Other Investing Cash Flow Items, Total | -0.05359 | -0.1183 | -0.0331 | -0.39194 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Grant (Stuart M) | Individual Investor | 14.2096 | 5132677 | 21753 | 2022-12-30 | LOW |
Eshelman (Fredric N) | Individual Investor | 4.4624 | 1611872 | -6963 | 2022-11-10 | LOW |
Ianchulev (Tsontcho M.D.) | Individual Investor | 3.3016 | 1192562 | -21316 | 2022-12-27 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5451 | 919322 | -8433 | 2022-12-31 | LOW |
Medical Strategy GmbH | Investment Advisor | 1.922 | 694259 | 0 | 2022-09-30 | LOW |
Avenue Capital Group | Investment Advisor/Hedge Fund | 1.5166 | 547807 | 547807 | 2022-12-31 | HIGH |
Mario (Ernest B) | Individual Investor | 1.0595 | 382706 | 6963 | 2021-11-17 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.9314 | 336432 | 336432 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.7987 | 288500 | 24400 | 2022-12-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.72 | 260067 | 6056 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 0.2507 | 90568 | 14153 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2035 | 73517 | 11900 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.1954 | 70581 | 1159 | 2022-12-31 | LOW |
Mather (Charles E IV) | Individual Investor | 0.1953 | 70544 | 22222 | 2022-06-16 | LOW |
Clasby (Jennifer G) | Individual Investor | 0.1842 | 66537 | 10835 | 2021-06-17 | |
Lee (Kenneth B Jr) | Individual Investor | 0.1787 | 64544 | 22222 | 2022-06-16 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.1326 | 47900 | 0 | 2022-12-31 | LOW |
Oak Family Advisors, LLC | Investment Advisor/Hedge Fund | 0.1276 | 46073 | -13113 | 2022-12-31 | MED |
BNY Mellon Asset Management | Investment Advisor | 0.1228 | 44374 | -1136 | 2022-12-31 | LOW |
Strahlman (Ellen R) | Individual Investor | 0.1192 | 43052 | 22865 | 2022-08-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Eyenovia, Inc. Company profile
Ettevõttest Eyenovia, Inc.
Eyenovia, Inc. on kliinilises staadiumis oftalmoloogiline ettevõte. Ettevõte arendab mikrodooside massiivi printimise (MAP) platvormitehnoloogial põhinevaid ravimeid. Ettevõtte tooteprogramm keskendub mikrodoosidega ravimite hilisema staadiumi arendamisele progresseeruva lühinägelikkuse, presbioopia ja müdriaasi raviks. Ettevõtte tootekandidaatide hulka kuuluvad MydCombi, MicroPine ja MicroLine. MydCombi on kombineeritud mikropreparaat (fenüülefriin-tropikamiid), mis on farmakoloogilise müdriaasi (silmade laienemine) kandidaat. MicroPine on paikselt manustatav ravim progresseeruva müoopia, silma seljaosa haiguse raviks, mis on seotud patoloogilise telgede pikenemise ja sclero-retinaalse venitusega. MicroLine on kandidaat, mis arendab pilokarpiini mikrodoosiga versiooni, mis on silmaravim, mis võib annusest sõltuvalt esile kutsuda mioosi ehk pupilli kokkutõmbumist.
Industry: | Pharmaceuticals (NEC) |
295 Madison Ave Ste 2400
NEW YORK
NEW YORK 10017
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com